IPO
LOGIN
OPEN A DEMAT ACCOUNT
IPO
Login
Open a
Demat
Account
HOME
ABOUT US
PRODUCTS
Equity
Currency
Commodity
IPO
Mutual Funds
PMS
SLBM
SERVICES
Investment Banking
Institutional Equities
Wealth Management
Depository
TRADE WITH SYSTEMATIX
Partner With Us
Trading Simplified
Payment Gateway
Link UPI
KYC Updation
ReKYC
(Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
Bank Details
Account Opening Process
RESEARCH
MARKETS
Overview
Equity
Derivatives
IPO
Mutual Funds
Commodity
Currency
Company Info
INVESTORS
Investor Login
Investor Relations
Investor Grievances
ODR
Scores
Downloads
Investor Charter
Information to Physical Shareholders
Procedure for Filing a Complaint
Investor Education
CONTACT US
Our Reach
Careers
OPEN A DEMAT ACCOUNT
HOME
ABOUT US
PRODUCTS
EQUITY
CURRENCY
COMMODITY
IPO
MUTUAL FUND
PMS
SLBM
SERVICES
INVESTMENT BANKING
INSTITUTIONAL EQUITIES
WEALTH MANAGEMENT
DEPOSITORY
TRADE WITH SYSTEMATIX
PARTNER WITH US
TRADING SIMPLIFIED
PAYMENT GATEWAY
LINK UPI
KYC UPDATION
ReKYC (Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
BANK DETAILS
ACCOUNT OPENING PROCESS
RESEARCH
MARKETS
OVERVIEW
EQUITY
DERIVATIVES
IPO
MUTUAL FUND
COMMODITY
CURRENCY
COMPANY INFO
INVESTORS
INVESTOR LOGIN
INVESTOR RELATIONS
INVESTOR GRIEVANCES
ODR
SCORES
DOWNLOADS
INVESTOR CHARTER
INFORMATION TO PHYSICAL SHAREHOLDERS
PROCEDURE FOR FILING A COMPLAINT
Investor Education
CONTACT US
OUR REACH
CAREERS
Equity
Derivatives
Currency
Mutual Fund
IPO Analysis
Daily Market Tracker
Gainers & Losers
Value & Volume Toppers
52 Week Highs & Lows
New Highs & Lows
Buyers & Sellers
Out/Under Performers
Bulk Deals
Block Deals
Unusual Volume
Rising Volume
Exchange Holidays
5 Days Up & Down
Index Movers
Index Overview
Top Sectors
News & Analysis
Pre Session Commentary
Mid Session Commentary
End Session Commentary
Quick Review
Market Beat
Stock Alert
Hot Pursuit
Foreign Markets
Economy News
Corporate News
Corporate Results
Other Markets
Futures Markets
Corporate Information
Company Snapshot
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Previous Quarter Comp
Director's Report
Score Board
Mutual Fund Holdings
Announcements
Peer Comparison
Technical Chart
Corporate Actions
Announcements
Book Closure
Board Meetings
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Name Change
Split Of Face Value
Event Calendar
Other Markets
ADR Prices
FII Investments
MF Investments
Forex Details
World Indices
GDR Prices
Equity
Derivative
Currency
Commodity
Mutual Fund
IPO
Price Analysis
Volume Analysis
News Analysis
Market Option
Other Option
Company Information
Gainers & Losers
52 Week High Low
News Highs and Low
Advances & Declines
Home
Market Info
Corporate Information
Company Snapshot
Company Snapshot
BSE
Suven Pharmaceuticals Ltd
BSE Code
543064
ISIN Demat
INE03QK01018
Book Value (₹)
76.54
NSE Symbol
SUVENPHAR
Div & Yield %
0.91
Market Cap (
₹
Cr.)
16,747.83
P/E *
43.89
EPS *
14.99
Face Value (₹)
1
* Profit to Earning Ratio
* Earning Per Share
Stock Price Details
Last Price (₹)
652.45
Change
13.05 (2.02%)
Best Buy (₹)
0.00
Best Sell (₹)
0.00
Today's Range
649.75 - 664.10
52-Week Range
427.05 - 767.00
Beta (1 Year)
0.55
Chart
1 Day
|
5 Day
|
3 Month
|
1 Year
|
5 Year
Corporate Announcements
Suven Pharmaceuticals Ltd - Suven Pharmaceuticals Limited - Other General Purpose
Suven Pharmaceuticals Ltd - Suven Pharmaceuticals Limited - Trading Window
Suven Pharmaceuticals Ltd - Suven Pharmaceuticals Limited - Trading Window
Suven Pharmaceuticals Ltd - Suven Pharmaceuticals Limited - Updates
Suven Pharmaceuticals Ltd - Suven Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Suven Pharmaceuticals receives revision in credit ratings
Suven Pharmaceuticals Ltd - Suven Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Suven Pharmaceuticals Ltd - Suven Pharmaceuticals Limited - Credit Rating
Suven Pharmaceuticals Ltd - Suven Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Suven Pharmaceuticals Ltd - Suven Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Corporate Details
Incorporation Year :
2018
Chairman :
Annaswamy Vaidheesh
Ownership Group :
Indian Private
Sector :
Pharmaceuticals
Industry :
Pharmaceuticals - Indian - Bulk Drugs & Formln
Registered Office :
Suven Pharmaceuticals Ltd
8-2-334 SDE Serene Chambers,
3 Floor Avenue 7 Road No 5,
Hyderabad,
Telangana - 500034,
Phone : 91-40-23549414/1142/3311,
Fax : 91-40-23541152
E-Mail :
khrao@suvenpharm.com
URL :
http://www.suvenpharm.com
Investor Returns
Period
Date
Price
Returns (%)
1Week
19-Apr-2024
642.30
2.43
1Month
26-Mar-2024
642.35
2.42
3Month
29-Jan-2024
684.10
-3.83
6Month
26-Oct-2023
568.95
15.63
1Year
26-Apr-2023
473.00
39.09
Mutual Funds Holding
Scheme Name
% Holding
Market Value
UTI-Flexi Cap Fund
1.21
296.39
DSP ELSS Tax Saver Fund
1.54
216.20
DSP Healthcare Fund
8.33
195.92
DSP Equity Opportunities Fund
1.51
162.97
HSBC Small Cap Fund
1.16
155.60
Peerset : Pharmaceuticals - Indian - Bulk Drugs & Formln
Company
Last Price (₹)
Change (%)
52Week High (₹)
52Week Low (₹)
Market Cap (₹ Cr.)
Sun Pharmaceuticals Industries Ltd
1,504.25
-1.07
1,638.70
922.55
360,919.96
Cipla Ltd
1,409.40
0.28
1,519.00
897.70
113,794.25
Dr Reddys Laboratories Ltd
6,253.25
0.58
6,505.50
4,383.40
104,315.63
Zydus Lifesciences Ltd
947.90
-0.32
1,031.30
482.55
95,380.92
Mankind Pharma Ltd
2,368.25
-1.27
2,488.65
1,240.75
94,869.36
Index Details
BSE 500, BSE HC, BSE SmallCap